Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
70 Leser
Artikel bewerten:
(0)

MedQuist Names Anthony D. James as Chief Financial Officer

MOUNT LAUREL, N.J., Nov. 22, 2010 /PRNewswire-FirstCall/ -- MedQuist Inc., a leading provider of integrated clinical documentation solutions for the U.S. healthcare industry today announced that Anthony D. James, the company's current Co-Chief Operating Officer, has been named the Company's Chief Financial Officer effective November 22, 2010. James will also continue to serve as the Company's Co-Chief Operating Officer.

James served as the Chief Operating Officer for Spheris Inc., a global outsource provider of clinical documentation technology and services, from 2006 until April 2010, when MedQuist and its majority shareholder, CBay Inc., purchased substantially all of the assets of Spheris. Prior to that, James served as the Chief Financial Officer for Spheris from 2001 to 2006. James joined Spheris in November 1999 as the company's Controller.

Prior to Spheris, James held a number of finance and accounting positions over a seven year tenure with Mariner Post-Acute Network. Additionally, he worked for two years in public accounting for Schoenauer, Musser & Co. James is a certified public accountant and received his B.A. in Accounting from the University of Northern Iowa.

Dominick Golio, who served as the Company's Chief Financial Officer until James' appointment, has decided to not relocate to Franklin, Tennessee where the Company finance group will be headquartered and has agreed to remain with the Company to assist with the transition of responsibilities to James, and thereafter pursue other business interests.

Peter Masanotti, MedQuist's CEO stated, "We appreciate all that Dom has done for MedQuist during a period of extraordinary change within the Company and our industry as a whole. We wish him well in his future endeavors."

MedQuist Inc.

CONTACT: Katie Weaver, Marketing Communications, +1-267-940-5765,
kweaver@medquist.com

Web Site: http://www.medquist.com/

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.